EBITDA

QuinStreet's major acquisition of HomeBuddy aims to reshape the digital home services market by combining scale with exclusive, high-intent contractor leads.

With a key presentation looming, Star Therapeutics aims to showcase its universal hemostatic therapy, VGA039, for von Willebrand disease.

With blockbuster sales from VYJUVEK, Krystal Biotech heads to J.P. Morgan with investors eager for news on its global growth and ambitious pipeline.

A tiny implant stimulating the vagus nerve offers new hope for severe RA. A landmark study now validates this bioelectric therapy for patients out of options.

Off The Hook's new luxury division leverages AI and an integrated model to secure ~$100M in listings and close 22 deals in its explosive first quarter.

A new integration brings Ceres AI's insights directly into the John Deere Operations Center, tackling data fragmentation for growers and insurers alike.

Amid a capacity crisis, a new model blending AI with human oversight gains traction, promising efficiency without sacrificing the crucial element of patient care.

With record Q3 earnings and strong analyst ratings, Red Violet is set to present its identity intelligence growth strategy at the prestigious Needham conference.

With pivotal Phase 2 data for its non-invasive skin cancer patch due in Q1, Medicus Pharma is advancing a diverse pipeline fueled by AI and strategic acquisitions.

A premium meal service enters the D.C. market not with ads, but with community aid and a rare, profitable business model that defies industry trends.

Acorn Energy partners with AIO Systems to bring AI-driven monitoring to cell towers and data centers, targeting a market projected to exceed $13 billion.

EMERGE Commerce CEO Ghassan Halazon unveils a new strategy, detailing past growth errors and a multi-year turnaround that pivots the firm to disciplined growth.

EchoStar's soaring stock price has triggered a conversion option for its 2030 notes, creating a pivotal choice between debt, cash, and equity.

AE Industrial acquires L3Harris's propulsion unit, reviving the iconic Rocketdyne name to modernize legacy engines and pioneer nuclear power for deep space.

A global RFA leader unveils a new identity, reflecting a strategic shift from pure engineering to a focus on the patient's quality of life.

A humanoid robot named Nylo will manage IntBot's CES booth entirely alone, a high-stakes, unscripted test of AI's readiness for the real world.

Ingevity divests its North Charleston CTO assets to Mainstream Pine Products, sharpening its focus on high-margin activated carbon and advanced polymers.

Fresh from a financial turnaround, Varvee Global expands its non-denim fabric capacity, signaling a major pivot from its denim legacy to capture India's textile boom.

In a major win, Rockwell Medical extends its DaVita supply deal through 2026 with a price hike, underscoring the value of its reliable supply chain.

Sanofi is investing up to $2.56 billion in Earendil Labs' AI platform to discover next-gen bispecific antibodies for complex autoimmune diseases.